Thank you for your email.

 

Please accept this as acknowledgement that your email has been received by
my office.

 

My office is closed from Thursday 23 December 2021, reopening Monday 10
January 2022, so there may be a delay in responding to your query.

 

In the meantime, you can find more information below:

 

General COVID-19 information and testing

 

All the latest COVID-19 information can be found at [1]covid19.govt.nz

 

Locations of interest [2]can be found here. You can also call Healthline
free on 0800 611 116 for health advice and information, including where to
get tested.

 

Vaccination

 

To get your COVID-19 vaccination head to
[3]bookmyvaccine.covid19.health.nz or to the [4]Healthpoint website to
find a vaccination site near you.

 

For help with My Vaccine Pass you can call 0800 222 478 or head to
[5]mycovidrecord.health.nz to get it online.

Managed Isolation

Anyone with queries regarding MIQ should contact +64 4 931 5720 if you’re
overseas (rates will apply) or 0800 476 647 if you’re in New Zealand.

You can also submit an enquiry via the [6]MIQ website.

 

Anyone with queries about changes to flights should
email [7][email address] with a copy of their original flight
ticket and their voucher, and details of the new flight number. This email
is monitored 24/7.

MIQ will continue to process [8]Emergency Allocation and [9]Exemption
requests throughout the holiday period. If you require an update on an
existing application then you can view the live status of your application
via the MIQ customer portal at any time.

There are still rooms to be released for January, February and March 2022.
Future room releases will be announced on the MIQ website and social media
platforms.

COVID-19 Protection Framework

 

If you have questions about the traffic light system, you can [10]make an
enquiry here.    

We appreciate your patience. 

Thanks again.
Authorised by Chris Hipkins MP, Parliament Buildings, Wellington

show quoted sections

Kia ora Will,

 

On behalf of Hon Chris Hipkins, Minister for COVID-19 Response, thank you
for your email.

 

The quantitative formulation is submitted to Medsafe and reviewed as part
of the evaluation process. The qualitative formulation is published in the
Datasheet
([1]https://www.medsafe.govt.nz/profs/Datash...), and
on Medsafe’s website, and is a complete reflection of the vaccine
ingredients. 

 
Information regarding the vaccine approval process can be found
here:  [2]https://www.medsafe.govt.nz/COVID-19/vac...

 

The vaccine is manufactured and tested according to  the requirements of
Good Manufacturing Practice and the site is regularly inspected by
regulators (for example the US FDA) to ensure that the quality meets these
requirements. Sites of manufacture are published on the Medsafe website. 

[3]https://www.medsafe.govt.nz/regulatory/P...

 

Many Thanks,

[4]cid:image001.jpg@01D433B3.8E157340 Daniel
Martin
Health
Private
Secretary

Office of
Hon Chris
Hipkins   

Minister
for
COVID-19
Response |
Minister
of
Education
| Minister
for the
Public
Service |
Leader of
the House

Parliament
Buildings,
Private
Bag 18041,
Wellington
6160, New
Zealand

 

show quoted sections